Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Grit Bio
company
About
Grit Bio develops cancer therapeutics with the goal of providing a safer approach to treating pharyngeal squamous cell carcinoma.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $255.98K
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Grit Bio develops cancer therapeutics with the goal of providing a safer approach to treating pharyngeal squamous cell carcinoma. The company was founded in 2017 and is headquartered in New York, NY.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$255.98K
Grit Bio has raised a total of
$255.98K
in funding over 2 rounds. Their latest funding was raised on
Feb 8, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 8, 2021 | Grant | $255.98K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Grit Bio is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
